Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19.


Journal

Current drug targets
ISSN: 1873-5592
Titre abrégé: Curr Drug Targets
Pays: United Arab Emirates
ID NLM: 100960531

Informations de publication

Date de publication:
2022
Historique:
received: 29 03 2022
revised: 31 05 2022
accepted: 15 06 2022
pubmed: 28 8 2022
medline: 15 12 2022
entrez: 27 8 2022
Statut: ppublish

Résumé

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the highly pathogenic and highly transmissible human coronavirus that is the causative agent for the worldwide COVID-19 pandemic. COVID-19 manifests predominantly as a respiratory illness with symptoms consistent with viral pneumonia, but other organ systems (e.g., kidney, heart, brain) can also become perturbed in COVID-19 patients. Accumulating data suggest that significant activation of the hemostatic system is a common pathological manifestation of SARS-CoV-2 infection. The clotting protein fibrinogen is one of the most abundant plasma proteins. Following activation of coagulation, the central coagulation protease thrombin converts fibrinogen to fibrin monomers, which selfassemble to form a matrix, the primary structural component of the blood clot. Severe COVID-19 is associated with a profound perturbation of circulating fibrinogen, intra- and extravascular fibrin deposition and persistence, and fibrin degradation. Current findings suggest high levels of fibrinogen and the fibrin degradation product D-dimer are biomarkers of poor prognosis in COVID-19. Moreover, emerging studies with in vitro and animal models indicate fibrin(ogen) as an active player in COVID-19 pathogenesis. Here, we review the current literature regarding fibrin(ogen) and COVID-19, including possible pathogenic mechanisms and treatment strategies centered on clotting and fibrin(ogen) function.

Identifiants

pubmed: 36029073
pii: CDT-EPUB-125886
doi: 10.2174/1389450123666220826162900
pmc: PMC10316333
mid: NIHMS1909300
doi:

Substances chimiques

Fibrin Fibrinogen Degradation Products 0
Fibrinogen 9001-32-5
Fibrin 9001-31-4

Types de publication

Review Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1593-1602

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL160046
Pays : United States

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Références

Br J Haematol. 1985 Aug;60(4):715-22
pubmed: 3896298
Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):
pubmed: 34183396
Thromb Res. 2021 Mar;199:143-148
pubmed: 33535120
Thromb Haemost. 1999 May;81(5):680-3
pubmed: 10365736
Ann Med. 2021 Dec;53(1):318-334
pubmed: 33706639
Matrix Biol Plus. 2019 Mar 19;1:100003
pubmed: 33543002
Curr Pharm Des. 2011;17(28):2987-3001
pubmed: 21861837
Front Immunol. 2018 Aug 20;9:1898
pubmed: 30177934
Thromb Haemost. 2012 Sep;108(3):419-26
pubmed: 22836683
Blood. 2015 Oct 22;126(17):2047-58
pubmed: 26228483
Infect Agent Cancer. 2021 Oct 30;16(1):62
pubmed: 34717691
J Thromb Thrombolysis. 2021 Nov;52(4):985-991
pubmed: 34019231
Cancer Res. 2010 Apr 1;70(7):2634-43
pubmed: 20233870
Medicine (Baltimore). 2021 Nov 24;100(47):e27861
pubmed: 34964754
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Soc Sci Med. 2021 Jan;268:113426
pubmed: 33199035
Lancet Haematol. 2020 Aug;7(8):e575-e582
pubmed: 32619411
Blood. 2015 Oct 15;126(16):1940-8
pubmed: 26324704
Int Rev Immunol. 2022;41(4):414-422
pubmed: 34678120
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Am J Respir Crit Care Med. 2020 Jul 1;202(1):1-4
pubmed: 32402207
Int J Mol Sci. 2020 Jul 21;21(14):
pubmed: 32708334
J Thromb Haemost. 2021 Dec;19(12):3062-3072
pubmed: 34538029
Clin Pharmacol Ther. 2022 Mar;111(3):614-623
pubmed: 34862791
J Clin Invest. 2007 Nov;117(11):3224-35
pubmed: 17932565
Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14482-14492
pubmed: 32518112
Nat Rev Nephrol. 2021 Jan;17(1):46-64
pubmed: 33077917
Chest. 2021 Jan;159(1):73-84
pubmed: 33038391
Thromb J. 2021 Nov 6;19(1):83
pubmed: 34742307
Mod Pathol. 2020 Nov;33(11):2156-2168
pubmed: 32879413
Microvasc Res. 2021 Nov;138:104224
pubmed: 34273359
Thromb Haemost. 2008 Dec;100(6):1185-92
pubmed: 19132247
Blood. 2022 Mar 3;139(9):1302-1311
pubmed: 34958662
Eur Respir J. 1993 Jul;6(7):971-7
pubmed: 8370446
Crit Care Med. 2021 Jul 1;49(7):e663-e672
pubmed: 33861545
Neth J Med. 2016 Dec;74(10):443-448
pubmed: 27966438
Nat Commun. 2021 Sep 30;12(1):5730
pubmed: 34593807
Blood. 2011 May 5;117(18):4953-63
pubmed: 21355090
Blood Adv. 2019 May 14;3(9):1519-1532
pubmed: 31076408
Am J Physiol Lung Cell Mol Physiol. 2008 Dec;295(6):L967-75
pubmed: 18836029
Lancet Infect Dis. 2020 Oct;20(10):1135-1140
pubmed: 32526193
Forensic Sci Med Pathol. 2021 Jun;17(2):279-296
pubmed: 33026628
Int J Environ Res Public Health. 2021 Jan 31;18(3):
pubmed: 33572570
Vascul Pharmacol. 2022 Feb;142:106950
pubmed: 34871770
Res Pract Thromb Haemost. 2021 May 18;5(4):e12525
pubmed: 34027292
J Thromb Haemost. 2021 Dec;19(12):2997-3007
pubmed: 34431201
Blood. 2019 Feb 7;133(6):511-520
pubmed: 30523120
Food Chem Toxicol. 2021 Feb;148:111974
pubmed: 33421462
Nat Commun. 2012;3:1227
pubmed: 23187627
Eur Rev Med Pharmacol Sci. 2021 Oct;25(19):5904-5912
pubmed: 34661248
Int J Lab Hematol. 2022 Aug;44(4):712-721
pubmed: 35266284
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
J Thromb Haemost. 2020 Aug;18(8):1849-1852
pubmed: 32588535
Chest. 2022 Mar;161(3):710-727
pubmed: 34592318
Atherosclerosis. 2000 Feb;148(2):209-14
pubmed: 10657556
Curr Opin Hematol. 2012 Sep;19(5):349-56
pubmed: 22759629
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7997-8003
pubmed: 34982463
J Thromb Thrombolysis. 2020 Jul;50(1):54-67
pubmed: 32415579
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211010973
pubmed: 34933579
Biochemistry. 1991 Oct 29;30(43):10363-70
pubmed: 1931959
Nat Rev Immunol. 2020 Jul;20(7):389-391
pubmed: 32439870
EClinicalMedicine. 2020 Jun 25;24:100434
pubmed: 32766543
Geroscience. 2021 Oct;43(5):2265-2287
pubmed: 34510338
Thromb Haemost. 2001 Oct;86(4):1040-6
pubmed: 11686322
Ann Clin Lab Sci. 2020 May;50(3):308-313
pubmed: 32581017
Am J Physiol Lung Cell Mol Physiol. 2018 Nov 1;315(5):L799-L809
pubmed: 30136609
Am J Respir Cell Mol Biol. 1993 Aug;9(2):213-20
pubmed: 8338688
Crit Care Med. 2020 Oct;48(10):e971-e975
pubmed: 32618700
Am J Emerg Med. 2012 Nov;30(9):1991-9
pubmed: 22795996
Blood Adv. 2022 Feb 8;6(3):1074-1087
pubmed: 34861681
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Curr Opin Pharmacol. 2022 Feb;62:43-59
pubmed: 34915400
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211045902
pubmed: 34590493
Respir Res. 2001;2(6):353-64
pubmed: 11737935
Nat Rev Neurosci. 2018 May;19(5):283-301
pubmed: 29618808
Elife. 2021 Mar 08;10:
pubmed: 33683204
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
PLoS One. 2021 Feb 11;16(2):e0246318
pubmed: 33571301
J Cardiothorac Vasc Anesth. 2021 Feb;35(2):389-397
pubmed: 32994131
Am J Respir Cell Mol Biol. 2002 Jun;26(6):650-8
pubmed: 12034563
Annu Rev Biochem. 1984;53:195-229
pubmed: 6383194
PLoS One. 2022 Jan 11;17(1):e0262482
pubmed: 35015795
PLoS Pathog. 2022 Jan 18;18(1):e1010227
pubmed: 35041705
JAMA Neurol. 2015 Aug;72(8):928-34
pubmed: 26030910
Res Pract Thromb Haemost. 2020 Oct 13;4(7):1178-1191
pubmed: 33043231
Blood. 2012 Apr 5;119(14):3342-51
pubmed: 22238323
TH Open. 2022 Jan 17;6(1):e1-e9
pubmed: 35059556
Int J Hematol. 2021 Jan;113(1):45-57
pubmed: 33161508
Trials. 2020 Sep 07;21(1):769
pubmed: 32895056
Blood Rev. 2021 Jul;48:100793
pubmed: 33419567
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
J Clin Invest. 2014 Aug;124(8):3590-600
pubmed: 24983320
J Clin Invest. 2004 Jun;113(11):1596-606
pubmed: 15173886
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):e13-e21
pubmed: 28228446
J Thromb Thrombolysis. 2021 Nov;52(4):999-1006
pubmed: 34047938
Neurobiol Aging. 2015 Feb;36(2):608-17
pubmed: 25475538
Ann Intern Med. 2021 May;174(5):655-662
pubmed: 33481642
Blood Adv. 2018 Jan 03;2(1):25-35
pubmed: 29344582
J Exp Med. 2007 Aug 6;204(8):1999-2008
pubmed: 17664291
Transfus Apher Sci. 2008 Feb;38(1):15-23
pubmed: 18282807
Blood. 2020 Dec 24;136(26):3062-3069
pubmed: 33367543
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):401-414
pubmed: 33196292

Auteurs

Kadri Kangro (K)

Department of Pathology and Laboratory Medicine, UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Alisa S Wolberg (AS)

Department of Pathology and Laboratory Medicine, UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Matthew J Flick (MJ)

Department of Pathology and Laboratory Medicine, UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH